SOLARASolara Active Pharma Sciences Ltd

    Solara Active Pharma Sciences swings to a ₹28.5 crore September-quarter profit as revenue grows 33%

    • Earnings
    • Pharmaceuticals

    Blacklitt Research2 min read

    Solara Active Pharma Sciences Limited has told the exchanges that it released its unaudited consolidated results for the quarter and half year ended 30 Sep 2026 on 16 Oct 2026. The company made a profit of ₹28.46 crore in the September quarter, against a loss of ₹10.10 crore a year earlier, and revenue from operations rose 33% to ₹417.34 crore from ₹313.54 crore.

    Revenue from operations was 9% above the ₹381.60 crore of the June 2026 quarter, and profit was above the ₹16.31 crore of that quarter. Profit before exceptional items and tax was ₹32.96 crore, against a loss of ₹10.10 crore a year earlier. An exceptional loss of ₹4.50 crore in the quarter brought profit before tax to ₹28.46 crore. The filing shows no tax expense in either period.

    Finance costs were ₹17.78 crore, against ₹20.83 crore a year earlier, and depreciation and amortisation expense was ₹26.64 crore, against ₹24.49 crore. For the half year, revenue from operations was ₹798.94 crore against ₹632.69 crore a year earlier, and profit was ₹44.77 crore against ₹0.42 crore.

    Inference

    The company moved from a loss to a profit on the year, with revenue about a third higher and finance costs lower. The filing shows total expenses rising by less than revenue, which is why the result turned positive.

    The profit is after an exceptional loss of ₹4.50 crore, for which the results statement refers to a note. The results show no tax charge, so profit before tax and profit after tax are the same in this statement.

    Reference: Original filing (PDF)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Latest posts